{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:25:51Z","timestamp":1736400351944,"version":"3.32.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":7853,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1017\/s1041610203009190","type":"journal-article","created":{"date-parts":[[2004,3,10]],"date-time":"2004-03-10T12:12:41Z","timestamp":1078920761000},"page":"195-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Patient Populations in Clinical Studies of Donepezil in Vascular Dementia"],"prefix":"10.1016","volume":"15","author":[{"given":"Raymond D.","family":"Pra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610203009190_bb0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000017126","article-title":"The effects of donepezil in Alzheimer\u2019s disease\u2014Results from a multinational trial","volume":"10","author":"Burns","year":"1999","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1017\/S1041610203009190_bb0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1212\/WNL.57.4.613","article-title":"A 24-week, randomized, doubleblind study of donepezil in moderate to severe Alzheimer\u2019s disease","volume":"57","author":"Feldman","year":"2001","journal-title":"Neurology"},{"key":"10.1017\/S1041610203009190_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJM199608013350507","article-title":"Evaluation of dementia","volume":"335","author":"Geldmacher","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1017\/S1041610203009190_bb0020","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.49.3.690","article-title":"Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia","volume":"49","author":"Gold","year":"1997","journal-title":"Neurology"},{"issue":"Suppl. 3","key":"10.1017\/S1041610203009190_bb0025","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","article-title":"Overlap between pathology of Alzheimer disease and vascular dementia","volume":"73","author":"Kalaria","year":"1999","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1017\/S1041610203009190_bb0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/WNL.57.3.481","article-title":"A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients","volume":"57","author":"Mohs","year":"2001","journal-title":"Neurology"},{"key":"10.1017\/S1041610203009190_bb0035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer\u2019s disease","volume":"50","author":"Rogers","year":"1998","journal-title":"Neurology"},{"key":"10.1017\/S1041610203009190_bb0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1017\/S1041610203009190_bb0045","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1021\/jm00024a009","article-title":"Synthesis and structure-activity relationships of acetylcholinesterase inhibitors","volume":"38","author":"Sugimoto","year":"1995","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1017\/S1041610203009190_bb0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1212\/WNL.57.3.489","article-title":"A 1-year, randomized, placebo- controlled study of donepezil in patients with mild to moderate AD","volume":"57","author":"Winblad","year":"2001","journal-title":"Neurology"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022404465X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022404465X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610203009190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T16:25:57Z","timestamp":1736353557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104161022404465X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":10,"alternative-id":["S104161022404465X"],"URL":"https:\/\/doi.org\/10.1017\/s1041610203009190","relation":{},"ISSN":["1041-6102"],"issn-type":[{"type":"print","value":"1041-6102"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Populations in Clinical Studies of Donepezil in Vascular Dementia","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610203009190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}